Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss
Myosteatosis is already present in half of the IPF population at diagnosis and impacts short-term survival after 2 years. Our findings highlight the importance of a fully comprehensive assessment of IPF patients to address early nutritional intervention and/or rehabilitation programs.
Authors
- Elisabetta Balestro (ORCID: https://orcid.org/0000-0003-1373-8197)
- G. Castelli (ORCID: https://orcid.org/0000-0002-5925-4035)
- Nicol Bernardinello
- Elisabetta Cocconcelli (ORCID: https://orcid.org/0000-0002-0343-1565)
- Chiara Giraudo (ORCID: https://orcid.org/0000-0003-0924-5883)
- Roberto Stramare (ORCID: https://orcid.org/0000-0002-1818-2290)
- Matteo Daverio (ORCID: https://orcid.org/0000-0002-8609-3724)
- Paolo Spagnolo (ORCID: https://orcid.org/0000-0002-1096-0596)
- Giulia Grisostomi (ORCID: https://orcid.org/0009-0005-8562-9207)
- Antonella Modugno
Institutions
- University of Padua (IT)
Publication Details
- Journal
- Respiration
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1159/000549895
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00